Cephalon, Inc. (CEPH)

$55.08 -0.15 (-0.27%)

11/30/2009 2:57 PM

CAPS Rating

Open

$55.21

Previous Close

$55.23

Daily Range

$54.96 - $55.40

52-Week Range

$52.55 - $81.35

Market Cap

$4.11B

P/E Ratio

13.82

Dividend (Yield)

N/A (N/A)

Volume

1,117,006

Average Daily Volume

2,601,000

CEPH VS S&P 500 (SPY)

Caps

Motley Fool CAPS is a community working together to find better stocks and to become better investors.

CNBC on Cephalon, Inc.November 23, 2009 – Ockham-RazorWire
CNBC on Cephalon, Inc.November 23, 2009 – Ockham-RazorWire
A Big Upgrade for Allos TherapeuticsNovember 23, 2009 – The Motley Fool
UPDATE 1-Cephalon delays Ception deal after mixed drug dataNovember 23, 2009 – Reuters
The Hottest Sector for 2010November 16, 2009 – The Motley Fool
UPDATE 1-Cephalon, Barr settle patent infringement suitNovember 12, 2009 – Reuters
3 Reasons You're Being Set Up to FailNovember 10, 2009 – The Motley Fool
5-Star Stocks on the UpswingNovember 05, 2009 – The Motley Fool
MFI Stock Review: Cephalon (CEPH)November 05, 2009 – Blog at The Motley Fool
UPDATE 1-Cephalon 3rd quarter profit risesOctober 27, 2009 – Reuters
Don't Miss This Cheap StockOctober 23, 2009 – The Motley Fool
Genzyme's Good News. Finally!September 25, 2009 – The Motley Fool
UPDATE 1-Cephalon sleep drug wins fast review for jet lagSeptember 24, 2009 – Reuters
Alkermes Needs Some Financial AlchemySeptember 23, 2009 – The Motley Fool
Pfizer's Paying $2.3 Billion Again? Oh, Wait, Never Mind.September 02, 2009 – The Motley Fool
J&J Would Rather Not SayAugust 24, 2009 – The Motley Fool
Get Ready for the BounceJuly 13, 2009 – The Motley Fool
Time to Get GreedyJuly 07, 2009 – The Motley Fool
Loss of a Settlement OptionJune 25, 2009 – The Motley Fool
4-Star Stocks Poised to Pop: GeoEyeJune 09, 2009 – The Motley Fool